언어 선택

Catenin beta-1

Catenin beta-1 분자 정보

영어 이름	Catenin beta 1	시판 약물 수	1
임상 약물 수	10	표적 별명	NEDSDV，OK/SW-cl.35，CTNNB1，PRO2286，Catenin Beta 1，Catenin (Cadherin-Associated Protein)， Beta 1， 88kDa，CTNNB，Catenin (Cadherin-Associated Protein)， Beta 1 (88kD)，Catenin (Cadherin-Associated Protein)， Beta 1，Catenin Beta-1，Beta-Catenin，Armadillo，MRD19，EVR7，beta Catenin，β-Catenin
최고 연구 개발 단계	Approved

영어 이름	Catenin beta 1
표적 별명	NEDSDV，OK/SW-cl.35，CTNNB1，PRO2286，Catenin Beta 1，Catenin (Cadherin-Associated Protein)， Beta 1， 88kDa，CTNNB，Catenin (Cadherin-Associated Protein)， Beta 1 (88kD)，Catenin (Cadherin-Associated Protein)， Beta 1，Catenin Beta-1，Beta-Catenin，Armadillo，MRD19，EVR7，beta Catenin，β-Catenin
시판 약물 수	1
임상 약물 수	10
최고 연구 개발 단계	Approved

Catenin beta-1 제품 목록

속성
Protein (2)
제품 라이브러리
온라인 (2)
종
Human (2)
태그
His Tag (1)His Tag & Avi Tag (1)
마커
Unconjugated (1)Biotin-labeled (1)

제품 번호	종	발현 시스템	제품 설명	단백질 구조	순도	특성
CA1-H51H3	Human	E. coli	Human Catenin beta-1 Protein, His Tag (MALS verified)
CA1-H81E3	Human	E. coli	Biotinylated Human Catenin beta-1 Protein, His,Avitag™ (MALS verified)

총 수량2

Catenin beta-1분자 배경

Wnt/β-catenin signaling has been broadly implicated in human cancers and experimental cancer models of animals. The nuclear accumulation of β-catenin has been shown to be positively correlated with poor clinical outcomes, such as cancer progression, invasion, metastasis, and recurrence, resulting in low survival rates.

Catenin beta-1분자 별명

CTNNB, EVR7, MRD19, NEDSDV, armadillo

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
CEQ-508	CEQ-508	Phase 2 Clinical	Marina Biotech	Adenomatous Polyposis Coli	상세
Foscenvivint	PRI-724; ICG-001; OP-724	Phase 2 Clinical	Prism Pharma Co Ltd, University Of Southern California	Colorectal Neoplasms; Hepatitis B; Hepatitis C; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Liver Cirrhosis; Liver Cirrhosis, Biliary; Pancreatic Neoplasms; Solid tumours	상세
Tegatrabetan	BC-2059; APL-121	Phase 2 Clinical	Allergan Plc	Adenomatous Polyps; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Ovarian Epithelial; Carcinoma, Pancreatic Ductal; Colorectal Neoplasms; Endometrial Neoplasms; Fibroma; Fibromatosis, Aggressive; Hepatoblastoma; Leukemia; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Neoplasms; Neuroblastoma; Osteosarcoma; Pancreatic Neoplasms; Sarcoma, Ewing; Solid tumours; Wilms Tumor	상세
Zolucatetide		Phase 2 Clinical	Parabilis Medicines Inc	Adenomatous Polyps	상세
Urbagen gene addition therapy (CTNNB1 Foundation)		Phase 2 Clinical	CTNNB1 Foundation	Neurodevelopmental Disorders	상세
Zolucatetide	FOG-001	Phase 2 Clinical	Parabilis Medicines Inc	Adenomatous Polyposis Coli; Carcinoma, Hepatocellular; Colorectal Neoplasms; Craniopharyngioma; Endometrial Neoplasms; Fibromatosis, Aggressive; Microsatellite instability-high cancer; Neoplasm Metastasis; Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Solid tumours	상세
E-7386	E-7386	Phase 2 Clinical	Eisai Co Ltd, Prism Pharma Co Ltd	Carcinoma, Hepatocellular; Colorectal Neoplasms; Endometrial Neoplasms; Gastrointestinal Neoplasms; Liver Neoplasms; Melanoma; Neoplasms; Solid tumours	상세
DPTX-3186	DPTX-3186; DPTX3186	Phase 1 Clinical	Dewpoint Therapeutics Inc	Solid tumours	상세
ALN-BCAT	ALN-BCAT	Phase 1 Clinical	Alnylam Pharmaceuticals Inc	Carcinoma, Hepatocellular	상세
ST-316	ST-316	Phase 1 Clinical	Sapience Therapeutics Inc	Colonic Neoplasms; Hematologic Neoplasms; Solid tumours	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Tetrandrine	NSC-77037; ES-3000; FF-0019	Approved	Escend Pharmaceuticals Inc		Mainland China	Silicosis; Lung Neoplasms	null	2015-05-19	Leukemia; Leukemia, Myeloid, Acute; Lung Neoplasms; Myelodysplastic Syndromes; Silicosis	상세

제품 리뷰

S***e2026-06-23
0사람들이 좋아합니다
Biotinylated Human Catenin beta-1 Protein, His,Avitag™ (MALS verified)
It is working very well, but the packaging could be optimized a lot more (5 kg of dry ice for one tube seems a bit exaggerated).